Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood, and the Molecular Microscope® (MMDx) Diagnostic System results in indication biopsies.
Kidney Transplant Rejection
Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in blood, and the Molecular Microscope® (MMDx) Diagnostic System results in indication biopsies.
Trifecta-Kidney cfDNA-MMDx Study
-
Tampa General Hospital, Tampa, Florida, United States, 33606
University of Maryland School of Medicine, Baltimore, Maryland, United States, 21201
The Johns Hopkins University, School of Medicine, Baltimore, Maryland, United States, 21205
Detroit Medical Center, Harper University Hospital of Wayne State University, Detroit, Michigan, United States, 48201
Henry Ford Hospital, Detroit, Michigan, United States, 48202
Barnes-Jewish Hospital, Washington University at St. Louis, Saint Louis, Missouri, United States, 63110
University Hospitals Cleveland Medical Ctr., Cleveland, Ohio, United States, 44106-5048
Cleveland Clinic, Cleveland, Ohio, United States, 44195
Intermountain Transplant Services, Murray, Utah, United States, 84107
Virginia Commonwealth University Medical Center, Richmond, Virginia, United States, 23298
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
to
ALL
No
University of Alberta,
Philip F Halloran, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Alberta
2026-12